Guangxi Liuzhou Pharm Co Ltd (603368) — Strategic Asset Allocation Index
Guangxi Liuzhou Pharm Co Ltd (603368) has a Strategic Asset Allocation Index of 18.1% as of June 2023. Strategic assets (PP&E of CN¥1.20 Billion plus long-term investments of CN¥-) total CN¥1.20 Billion, measured against net assets of CN¥6.63 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Guangxi Liuzhou Pharm Co Ltd Strategic Asset Allocation Index (2011–2021)
This chart shows how Guangxi Liuzhou Pharm Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2011 to 2021. As of June 2023, the index stands at 18.1%, representing strategic assets of CN¥1.20 Billion against net assets of CN¥6.63 Billion CNY. Explore 603368 cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Guangxi Liuzhou Pharm Co Ltd (2011–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Guangxi Liuzhou Pharm Co Ltd from 2011 to 2021, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Guangxi Liuzhou Pharm Co Ltd (603368) market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 20.9% | CN¥1.21 Billion | CN¥1.21 Billion | CN¥- | CN¥5.81 Billion | ▲ +6.3 pp |
| 2020 | 14.5% | CN¥791.22 Million | CN¥791.22 Million | CN¥- | CN¥5.44 Billion | ▼ -0.2 pp |
| 2019 | 14.8% | CN¥687.23 Million | CN¥687.23 Million | CN¥- | CN¥4.66 Billion | ▼ -2.0 pp |
| 2018 | 16.7% | CN¥676.73 Million | CN¥601.69 Million | CN¥75.05 Million | CN¥4.05 Billion | ▲ +0.2 pp |
| 2017 | 16.6% | CN¥590.82 Million | CN¥515.78 Million | CN¥75.05 Million | CN¥3.57 Billion | ▲ +3.5 pp |
| 2016 | 13.1% | CN¥422.77 Million | CN¥371.05 Million | CN¥51.72 Million | CN¥3.24 Billion | ▼ -8.8 pp |
| 2015 | 21.8% | CN¥296.98 Million | CN¥296.98 Million | CN¥- | CN¥1.36 Billion | ▲ +6.4 pp |
| 2014 | 15.5% | CN¥181.62 Million | CN¥181.62 Million | CN¥- | CN¥1.17 Billion | ▲ +1.4 pp |
| 2013 | 14.1% | CN¥70.73 Million | CN¥70.73 Million | CN¥- | CN¥501.00 Million | ▲ +10.3 pp |
| 2012 | 3.8% | CN¥14.49 Million | CN¥14.49 Million | CN¥- | CN¥378.59 Million | ▲ +0.6 pp |
| 2011 | 3.2% | CN¥8.81 Million | CN¥8.81 Million | CN¥- | CN¥274.23 Million | — |